ITB institute
Research institute
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (28)
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Astrocytic IGF-IRs induce adenosine-mediated inhibitory downregulation and improve sensory discrimination
Journal of Neuroscience, Vol. 41, Núm. 22, pp. 4768-4781
-
GSK-3 and Tau: A Key Duet in Alzheimer's Disease
Cells, Vol. 10, Núm. 4
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis
Autophagy, Vol. 16, Núm. 7, pp. 1279-1295
-
Editorial: Shaping the Brain by Neuronal Cytoskeleton: From Development to Disease and Degeneration
Frontiers in Cellular Neuroscience
2019
-
Distinct functions for mammalian CLASP1 and -2 during neurite and axon elongation
Frontiers in Cellular Neuroscience, Vol. 13
-
Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain
Frontiers in Aging Neuroscience, Vol. 11
-
Role of tau N-terminal motif in the secretion of human tau by End Binding proteins
PLoS ONE, Vol. 14, Núm. 1
2018
-
Ovarian function modulates the effects of long-chain polyunsaturated fatty acids on the mouse cerebral cortex
Frontiers in Cellular Neuroscience, Vol. 12
2017
-
Atypical, non-standard functions of the microtubule associated Tau protein
Acta neuropathologica communications, Vol. 5, Núm. 1, pp. 91
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies
Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 6, pp. 653-661
-
Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system
Neurobiology of Disease, Vol. 88, pp. 44-54
-
Tau Structures
Frontiers in Aging Neuroscience, Vol. 8, Núm. NOV
2015
-
Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake
Neurobiology of Disease, Vol. 74, pp. 325-335
-
Tau regulates the localization and function of End-binding proteins 1 and 3 in developing neuronal cells
Journal of Neurochemistry, Vol. 133, Núm. 5, pp. 653-667
2014
-
Crosstalk between axonal classical microtubule-associated proteins and end binding proteins during axon extension: Possible implications in neurodegeneration
Journal of Alzheimer's Disease, Vol. 40, Núm. S1